Magrolimab in combination with azacitidine for patients with untreated higher-risk myelodysplastic syndromes: 5F9005 phase 1b study results

Authors
Publication date
1 January 2022
Publisher
'Royal College of Obstetricians & Gynaecologists (RCOG)'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Supporting member

    Oxford University Research Archive

    redirect
    oaioai:ora.ox.ac.uk:uuid:5918f1de...
    Last time updated on 21/11/2022